TrialDiabetes, obesity & metabolism2019

Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial.

Wenying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.